Qi Zhou
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Immunopathological Profile of Angiogenesis-Related Markers in Subgroups of EGFR-Mutated Lung Adenocarcinomas.
Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Published: August 29, 2025
Sema3A Affect Osteolytic Bone Metastasis of Non-small Cell Lung Cancer.
Journal: Recent patents on anti-cancer drug discovery
Published: January 15, 2024
The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and sensitivity to TKI in ph-like ALL.
Journal: Journal of cellular and molecular medicine
Published: October 11, 2023
Visually controlled pulsatile release of insulin from chitosan poly-acrylic acid nanobubbles triggered by focused ultrasound.
Journal: International journal of pharmaceutics
Published: April 11, 2023
Author Correction: ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation.
Journal: Nature communications
Published: April 04, 2023
Efficacy and safety of EGFR-TKIs in combination with angiogenesis inhibitors as first-line therapy for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and meta-analysis.
Journal: BMC pulmonary medicine
Published: November 24, 2022
Local resection versus radical resection for early-stage rectal cancer: a systematic review and meta-analysis.
Journal: International journal of colorectal disease
Published: May 16, 2022
Semaphorin 3F induces colorectal cancer cell chemosensitivity by promoting P27 nuclear export.
Journal: Frontiers in oncology
Published: March 19, 2022
ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation.
Journal: Nature communications
Published: August 13, 2020
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 05, 2019
ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield.
Journal: Nature communications
Published: April 29, 2018
ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway.
Journal: International journal of oncology
Published: October 31, 2017
Last Updated: 09/26/2026